Guys we're 4 days from Dec 2013. It's now 12 months since Phase 1/2a ended. Histogen has not announced any news about their estimated date for initiation of Phase 2b. There is no draft protocol either. Their merger deal fell through as well.
How do you guys feel? Will 2014 be just like 2013? Apart from attending conferences all operations on Hair stimulating complex have halted!
I wish we didn't even know about Histogen...that way we wouldn't be so disappointed in not being able to use it, even though the science is solid and efficacy is proven
Thinning87 I know you hate it when I make these posts BUT I had to...getting so tired of waiting when we are still where we were exactly 12 months ago!
That's how i feel too... I had belief in Histogen..
All we can do is to ask Spencer to interview Gail Naughton to get answers... So we could have a better picture of what's happening..
Earlier today I asked Dr. Cole if Histogen presented anything new at the October, 2013 hair restoration surgeon's conference in San Francisco. He said they were a no-show. I personally hope that something better than Propecia, Avodart, Rogaine and PRP will come our way soon. Ideally, I'd like to see things move a LOT faster than they are. There have actually been many studies reporting success. I know there were some cancer concerns related to injecting bioengineered stem cell concoctions into scalps. The FDA approval process can sometimes be stalled by any number of technical issues.
As for now, advancements in regenerative medicine appear to be having the greatest impact on the future of hair restoration.
35YrsAfter also posts as CITNews and works at Dr. Cole's office
forhair.com
Cole Hair Transplant
1045 Powers Place
Alpharetta, Georgia 30009
Phone 678-566-1011
email 35YrsAfter at chuck@forhair.com
I am not a doctor and the content of my posts are my opinions, not medical advice.
Please feel free to call or email me with any questions. Ask for Chuck
Has Histogen seriously been derailed that much? This caught me off guard.
I always thought the 2015/2016 Asia release was basically guaranteed and just the north American timeline was more of a up in the air type situation due to red tape and tighter trials.
Histogen was the one I was always most excited for. IS this just the forum spazzing out or is Histogen way off course for the 2015/16 asia release?
So today you learned a new lesson: making up facts and timelines about a cure isn't always the best way to approach the problem.
The Aderans folks put out an encouraging video presentation of their technology about 8 years ago. After watching this presentation, I came away with the impression that they had already pretty much achieved their goals. Apparently not. It would be interesting to know what technical difficulties they ran into. As far as Histogen goes, Dr. Cole doesn't have much confidence in what they have been able to achieve so far.
35YrsAfter also posts as CITNews and works at Dr. Cole's office
forhair.com
Cole Hair Transplant
1045 Powers Place
Alpharetta, Georgia 30009
Phone 678-566-1011
email 35YrsAfter at chuck@forhair.com
I am not a doctor and the content of my posts are my opinions, not medical advice.
Please feel free to call or email me with any questions. Ask for Chuck
Has Histogen seriously been derailed that much? This caught me off guard.
I always thought the 2015/2016 Asia release was basically guaranteed and just the north American timeline was more of a up in the air type situation due to red tape and tighter trials.
Histogen was the one I was always most excited for. IS this just the forum spazzing out or is Histogen way off course for the 2015/16 asia release?
It's partly spazzing I think. All it means is that Histogen are back to where they were before the reverse merger, doesn't it? They've always had trouble getting funding, as a lot of small biotech companies with all their major products going through trials tend to. Provided they didn't put all their eggs in one basket with the restorgenex thing, they should have a plan B and C. They made it through phase 1 without going public, so maybe they'll just look elsewhere for funding and do what they did before. Sure, this whole thing might have set them back a few months, but they're professionals who understand the industry and what it takes to get a product through to market/FDA approval and they'll have thought things through I'm sure. They still have a potentially billion-dollar product that's just 2-3 years away from a release.
Has Histogen seriously been derailed that much? This caught me off guard.
I always thought the 2015/2016 Asia release was basically guaranteed and just the north American timeline was more of a up in the air type situation due to red tape and tighter trials.
Histogen was the one I was always most excited for. IS this just the forum spazzing out or is Histogen way off course for the 2015/16 asia release?
in 2007/8 i and many were excited about intercytex and aderans. This is just history repeating itself.
Has Histogen seriously been derailed that much? This caught me off guard.
I always thought the 2015/2016 Asia release was basically guaranteed and just the north American timeline was more of a up in the air type situation due to red tape and tighter trials.
Histogen was the one I was always most excited for. IS this just the forum spazzing out or is Histogen way off course for the 2015/16 asia release?
Aderans had a lot of technology too, but they shut down due to financial issues. That said, the fact that Histogen are maybe only 1 trial away from making some money with their product in Asia means that Gail will do whatever it takes to see it through. She's very experienced with this sort of thing from what I've heard - and HSC is the best near-term solution to early MPB I've seen.
The Aderans folks put out an encouraging video presentation of their technology about 8 years ago. After watching this presentation, I came away with the impression that they had already pretty much achieved their goals. Apparently not. It would be interesting to know what technical difficulties they ran into. As far as Histogen goes, Dr. Cole doesn't have much confidence in what they have been able to achieve so far.
35YrsAfter also posts as CITNews and works at Dr. Cole's office
forhair.com
Cole Hair Transplant
1045 Powers Place
Alpharetta, Georgia 30009
Phone 678-566-1011
email 35YrsAfter at chuck@forhair.com
I am not a doctor and the content of my posts are my opinions, not medical advice.
Please feel free to call or email me with any questions. Ask for Chuck
The greater number of financing options available to publicly held companies is a primary reason to undergo a reverse takeover.
As per their CEO, it is not a secret that Histogen has trouble to get the appropriate funds to pursue research. Their reverse merge attempt should be considered in this light, although it does not imply that they are shutting anything down for the moment. But delays are very likely to occur.
delays?
there's very little chance of them starting phase2 next year - probably pushed that back by 2/3 years
The reality is that stratus are more or less dead in the water. Histogen have other things going on as well, not just their HSC, so funding will come in time.
Aderans had a lot of technology too, but they shut down due to financial issues. That said, the fact that Histogen are maybe only 1 trial away from making some money with their product in Asia means that Gail will do whatever it takes to see it through. She's very experienced with this sort of thing from what I've heard - and HSC is the best near-term solution to early MPB I've seen.
Leave a comment: